BG107857A - Лактамни съединения и фармацевтичното им използване - Google Patents

Лактамни съединения и фармацевтичното им използване Download PDF

Info

Publication number
BG107857A
BG107857A BG107857A BG10785703A BG107857A BG 107857 A BG107857 A BG 107857A BG 107857 A BG107857 A BG 107857A BG 10785703 A BG10785703 A BG 10785703A BG 107857 A BG107857 A BG 107857A
Authority
BG
Bulgaria
Prior art keywords
group
substituent
groups
ring
acyl
Prior art date
Application number
BG107857A
Other languages
Bulgarian (bg)
English (en)
Inventor
Yukio Iino
Takao Ikenoue
Nobuo Kondo
Hiroyuki Matsueda
Toshihiro Hatanaka
Ryusuke Hirama
Yoko Masuzawa
Fumio Ohta
Akiyo Yamazaki
Original Assignee
Ajinomoto Co.,Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co.,Inc. filed Critical Ajinomoto Co.,Inc.
Publication of BG107857A publication Critical patent/BG107857A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
BG107857A 2000-12-01 2003-05-29 Лактамни съединения и фармацевтичното им използване BG107857A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000367175 2000-12-01
PCT/JP2001/010435 WO2002044180A1 (fr) 2000-12-01 2001-11-29 Composes de lactame et leur utilisation medicale

Publications (1)

Publication Number Publication Date
BG107857A true BG107857A (bg) 2004-06-30

Family

ID=18837660

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107857A BG107857A (bg) 2000-12-01 2003-05-29 Лактамни съединения и фармацевтичното им използване

Country Status (26)

Country Link
US (3) US7153850B2 (pt)
EP (1) EP1346993B1 (pt)
JP (2) JP3826400B2 (pt)
KR (1) KR100826818B1 (pt)
CN (2) CN1269818C (pt)
AT (1) ATE446297T1 (pt)
AU (3) AU2002218502B2 (pt)
BG (1) BG107857A (pt)
BR (1) BR0115852A (pt)
CA (1) CA2430124C (pt)
CZ (1) CZ20031520A3 (pt)
DE (1) DE60140270D1 (pt)
ES (1) ES2331299T3 (pt)
HU (1) HUP0400806A3 (pt)
IL (1) IL156158A0 (pt)
MX (1) MXPA03004876A (pt)
NO (1) NO325401B1 (pt)
NZ (1) NZ526164A (pt)
PL (1) PL362835A1 (pt)
RU (1) RU2287530C2 (pt)
SK (1) SK6582003A3 (pt)
TW (1) TWI241302B (pt)
UA (1) UA76969C2 (pt)
WO (1) WO2002044180A1 (pt)
YU (1) YU42603A (pt)
ZA (1) ZA200304100B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0115852A (pt) 2000-12-01 2003-12-23 Ajinomoto Kk Composto de lactama ou um seu sal farmaceuticamente aceitável, agente para aumentar a capacidade de transporte de açúcar, agentes hipoglicêmico e para prevenir e/ou tratar diabetes, neuropatia periférica diabética, nefropatia diabética, retinopatia diabética, macroangiopatia diabética, tolerância prejudicada à glicose ou adipose, e, composição farmacêutica
AU2004210268B8 (en) * 2003-02-07 2009-06-04 Ajinomoto Co., Inc. Therapeutic agents for diabetes
WO2005042536A1 (ja) 2003-10-31 2005-05-12 Ajinomoto Co., Inc. 複素環を有する新規縮合多環式化合物及びその医薬用途
WO2005068467A1 (ja) * 2004-01-14 2005-07-28 Ajinomoto Co., Inc. 新規縮環化合物
WO2006118341A1 (ja) * 2005-04-28 2006-11-09 Ajinomoto Co., Inc. 新規ラクタム化合物
JP5672699B2 (ja) 2007-04-11 2015-02-18 味の素株式会社 血糖降下作用化合物のスクリーニング法
WO2008136393A1 (ja) * 2007-04-27 2008-11-13 Ajinomoto Co., Inc. ラクタム化合物の結晶形およびその製造方法
WO2008139574A1 (ja) * 2007-04-27 2008-11-20 Ajinomoto Co., Inc. ラクタム化合物の結晶形およびその製造方法
WO2008139575A1 (ja) * 2007-04-27 2008-11-20 Ajinomoto Co., Inc. 経口投与用製剤
CN101619041B (zh) * 2008-07-02 2012-07-04 重庆华邦制药股份有限公司 一种二酮基含氮环化合物的合成方法及其中间体
JP2012180282A (ja) * 2009-07-02 2012-09-20 Ajinomoto Co Inc ラクタム化合物の製造方法およびその製造中間体
JP2012180283A (ja) * 2009-07-02 2012-09-20 Ajinomoto Co Inc ラクタム化合物の製造方法およびその製造中間体
KR20170095850A (ko) * 2014-12-22 2017-08-23 이에이 파마 가부시키가이샤 각막 상피 장애 치료제
WO2019018185A1 (en) 2017-07-15 2019-01-24 Arisan Therapeutics Inc. ENANTIOMERICALLY PURE ADAMATANE DERIVATIVES FOR THE TREATMENT OF FILOVIRUS INFECTIONS
MX2021008937A (es) * 2019-01-23 2021-11-12 Glycolysis Biomed Co Ltd Compuestos de beta-lactama o sales de los mismos para su uso en la prevencion o tratamiento de accion prolongada del trastorno del metabolismo de la glucosa.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US48847A (en) * 1865-07-18 Improvement in vessels for reception and transportation of night-soil
US189597A (en) * 1877-04-17 Improvement in portable wash-stands
AU8592598A (en) 1997-07-30 1999-02-22 Wyeth Tricyclic vasopressin agonists
JP4204657B2 (ja) 1997-12-05 2009-01-07 有限会社ケムフィズ 糖尿病の予防・治療剤
BR0115852A (pt) 2000-12-01 2003-12-23 Ajinomoto Kk Composto de lactama ou um seu sal farmaceuticamente aceitável, agente para aumentar a capacidade de transporte de açúcar, agentes hipoglicêmico e para prevenir e/ou tratar diabetes, neuropatia periférica diabética, nefropatia diabética, retinopatia diabética, macroangiopatia diabética, tolerância prejudicada à glicose ou adipose, e, composição farmacêutica
AU2004210268B8 (en) 2003-02-07 2009-06-04 Ajinomoto Co., Inc. Therapeutic agents for diabetes

Also Published As

Publication number Publication date
AU1850202A (en) 2002-06-11
JP3826400B2 (ja) 2006-09-27
JP4505753B2 (ja) 2010-07-21
US7153850B2 (en) 2006-12-26
US20080096862A1 (en) 2008-04-24
RU2287530C2 (ru) 2006-11-20
AU2002218502B2 (en) 2006-09-21
US20040048847A1 (en) 2004-03-11
ZA200304100B (en) 2004-08-22
HUP0400806A3 (en) 2007-11-28
CN1487940A (zh) 2004-04-07
UA76969C2 (en) 2006-10-16
BR0115852A (pt) 2003-12-23
IL156158A0 (en) 2003-12-23
PL362835A1 (en) 2004-11-02
AU2006241377A1 (en) 2006-12-14
ATE446297T1 (de) 2009-11-15
NO325401B1 (no) 2008-04-21
JPWO2002044180A1 (ja) 2004-04-02
AU2006241377B2 (en) 2009-01-08
WO2002044180A1 (fr) 2002-06-06
KR100826818B1 (ko) 2008-05-02
JP2006213732A (ja) 2006-08-17
NO20032439L (no) 2003-07-18
DE60140270D1 (de) 2009-12-03
EP1346993A4 (en) 2005-12-21
CN1269818C (zh) 2006-08-16
YU42603A (sh) 2006-03-03
CN1911915A (zh) 2007-02-14
CZ20031520A3 (cs) 2003-10-15
CA2430124A1 (en) 2002-06-06
CN100577651C (zh) 2010-01-06
US7326701B2 (en) 2008-02-05
TWI241302B (en) 2005-10-11
EP1346993A1 (en) 2003-09-24
SK6582003A3 (en) 2003-09-11
CA2430124C (en) 2011-01-11
EP1346993B1 (en) 2009-10-21
MXPA03004876A (es) 2004-01-27
US20060189597A1 (en) 2006-08-24
KR20030051893A (ko) 2003-06-25
US7632830B2 (en) 2009-12-15
NO20032439D0 (no) 2003-05-28
HUP0400806A2 (hu) 2004-07-28
ES2331299T3 (es) 2009-12-29
NZ526164A (en) 2004-09-24

Similar Documents

Publication Publication Date Title
US7326701B2 (en) Lactam compounds and pharmaceutical use thereof
EP1786773B1 (en) Isoindolin-1-one derivatives
US20030144338A1 (en) Tyrosine phosphatase inhibitors
RU2720488C2 (ru) Замещенные амино шестичленные насыщенные гетероалициклы в качестве ингибиторов dpp-iv длительного действия
Mano et al. Novel imidazole compounds as a new series of potent, orally active inhibitors of 5-lipoxygenase
CN109641852B (zh) 作为gpr40-和gpr120-激动剂的磺酰胺
OA12631A (fr) Amides d'acide anthranilique avec une chaîne latérale hétéroarylsulfonyle, procédé our leur préparation, leur utilisation comme médeicament ou comme agent de diagnostic et préparations pharmaceutiquescontenant lesdits composés.
EP1981842A2 (fr) Derives de sulfonamides, leur preparation et leur application en therapeutique
JP2005526024A (ja) インスリン分泌を阻害するための化合物及びそれに関連する方法
US20230202986A1 (en) Substituted imidazole salt compounds, preparation method thereof, pharmaceutical composition thereof and application thereof
CN113454077A (zh) 用于治疗hbv感染或hbv诱发的疾病的酰胺衍生物
US20060258637A1 (en) Fused polycyclic compounds
KR20040089106A (ko) 벤즈아제핀 화합물의 고체 염 및 약제학적 화합물의제조에서 이의 용도
JPH05331129A (ja) カフェー酸誘導体及びそれを含む医薬組成物
JP2022542613A (ja) ヒトａｔｇｌの阻害剤
JP3562770B2 (ja) ベンズアゼピン−２−オン誘導体
FR2932480A1 (fr) Phenyl-alkyl-piperazines ayant une activite modulatrice du tnf
BE843281A (fr) Nouvelles 10-(omega-(benzoylpiperidino)alkyl) phensothiazines, utiles notamment comme agents tranquillisants, et leur procede de preparation